Compare AU

Compare ROBO vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X Robo Global Robotics & Automation ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X Robo Global Robotics & Automation ETF (ROBO) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

ROBO

CURE

Popularity

Low

Low

Pearlers invested

549

85

Median incremental investment

$639.52

$616.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,025.22

$1,410.92

Average age group

26 - 35

> 35


Key Summary

ROBO

CURE

Strategy

ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

Symbotic Inc Ordinary Shares - Class A (2.15 %)

Celestica Inc Ordinary Shares (Subordinate Voting) (1.93 %)

NVIDIA Corp (1.91 %)

Viking Therapeutics Inc (3.00 %)

Gilead Sciences Inc (2.76 %)

Alnylam Pharmaceuticals Inc (2.76 %)

Top 3 industries

Information Technology (40.93 %)

Industrials (39.97 %)

Health Care (19.10 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (80.07 %)

Canada (19.93 %)

United States (100.00 %)

Management fee

0.82 %

0.45 %


Key Summary

ROBO

CURE

Issuer

Global X

Global X

Tracking index

ROBO Global Robotics and Automation TR Index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.82 %

0.45 %

Price

$73.64

$50.39

Size

$221.309 million

$39.185 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

3.87 %

4.24 %

Market

ASX

ASX

First listed date

14/09/2017

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

ROBO

CURE

Popularity

Low

Low

Pearlers invested

549

85

Median incremental investment

$639.52

$616.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,025.22

$1,410.92

Average age group

26 - 35

> 35


Pros and Cons

ROBO

CURE

Pros

  • Higher price growth

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower distribution yield

  • Lower price growth

ROBO

CURE

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home